Quotes with Resistance & Support
Market Information

Buy GSK Pharma, target of Rs 1340: Hem Securities

Posted on: April 19th 2009 in Brokerage Recommendations.

Hem Securities has initiated a buy rating on GlaxoSmithKline Pharmaceuticals with a target price of Rs 1340 in its April 16, 2009 research report. “GlaxoSmithKline Pharmaceuticals has registered good set of numbers for the quarter ended December 2008. …

Read More..

read more

Breakouts

+ve 30 DMA    50 DMA    150 DMA    200 DMA
-ve 30 DMA    50 DMA    150 DMA    200 DMA

Latest Query

Samrudhiglobal.com wishing you and your friends and family Advance xmas and Happy New year...view more »
- by Sam
Status: Awaiting reply

Market Stats

Search Our Archives

Latest Investment Idea

Recent Comments